We are represented with a lecture at the web seminar Biotech vs. SARS-CoV-2: A BioBilanz. You can register on the event page.
Excerpt from the announcement:
“The SARS-CoV-2 pandemic challenges us: Socially, economically and scientifically.
The sciences have accepted the challenge, above all biotechnology:
With sequencing, PCR and antigen detection, it was methods of biotechnology that enabled the pathogen to be identified quickly and provided solid and inexpensive detection systems on a large scale. The mRNA technology led to the development and worldwide application of a novel, very effective vaccine at record speed. "